GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » HH Biotechnology Holdings Co (OTCPK:HHBT) » Definitions » Cyclically Adjusted Revenue per Share

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Cyclically Adjusted Revenue per Share : $0.00 (As of Sep. 2016)


View and export this data going back to . Start your Free Trial

What is HH Biotechnology Holdings Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

HH Biotechnology Holdings Co's adjusted revenue per share for the three months ended in Sep. 2016 was $0.138. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2016.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-23), HH Biotechnology Holdings Co's current stock price is $0.0003. HH Biotechnology Holdings Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2016 was $0.00. HH Biotechnology Holdings Co's Cyclically Adjusted PS Ratio of today is .


HH Biotechnology Holdings Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for HH Biotechnology Holdings Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HH Biotechnology Holdings Co Cyclically Adjusted Revenue per Share Chart

HH Biotechnology Holdings Co Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

HH Biotechnology Holdings Co Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HH Biotechnology Holdings Co's Cyclically Adjusted Revenue per Share

For the Real Estate Services subindustry, HH Biotechnology Holdings Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HH Biotechnology Holdings Co's Cyclically Adjusted PS Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, HH Biotechnology Holdings Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HH Biotechnology Holdings Co's Cyclically Adjusted PS Ratio falls into.



HH Biotechnology Holdings Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HH Biotechnology Holdings Co's adjusted Revenue per Share data for the three months ended in Sep. 2016 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2016 (Change)*Current CPI (Sep. 2016)
=0.138/102.4000*102.4000
=0.138

Current CPI (Sep. 2016) = 102.4000.

HH Biotechnology Holdings Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200612 0.332 77.793 0.437
200703 0.135 78.884 0.175
200706 0.246 79.357 0.317
200709 0.162 81.276 0.204
200712 0.279 82.911 0.345
200803 0.245 85.485 0.293
200806 0.188 85.058 0.226
200809 0.200 85.057 0.241
200812 0.187 83.956 0.228
200903 0.146 84.457 0.177
200906 0.148 83.615 0.181
200909 0.175 84.369 0.212
200912 0.277 85.386 0.332
201003 0.152 86.316 0.180
201006 0.168 85.886 0.200
201009 0.166 87.267 0.195
201012 0.143 89.289 0.164
201103 0.146 91.154 0.164
201106 0.158 91.612 0.177
201109 0.153 92.711 0.169
201112 0.149 92.885 0.164
201203 0.151 94.367 0.164
201206 0.159 93.495 0.174
201209 0.161 94.482 0.174
201212 0.161 95.237 0.173
201303 0.148 96.372 0.157
201306 0.195 95.984 0.208
201309 0.161 97.332 0.169
201312 0.159 97.624 0.167
201403 0.192 98.600 0.199
201406 0.160 98.200 0.167
201409 0.156 98.900 0.162
201412 0.171 99.000 0.177
201503 0.161 99.900 0.165
201506 0.148 99.500 0.152
201509 0.126 100.500 0.128
201512 0.162 100.600 0.165
201603 0.131 102.200 0.131
201606 0.136 101.400 0.137
201609 0.138 102.400 0.138

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


HH Biotechnology Holdings Co  (OTCPK:HHBT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


HH Biotechnology Holdings Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of HH Biotechnology Holdings Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 69 Heping North Street, C-Site, 25th - 26th Floor, Presidential Building, Heping District, Shenyang, CHN, 110003
HH Biotechnology Holdings Co is engaged in developing, producing and marketing of healthy food, supplements, medicine, and cosmetics.
Executives
Yizhao Zhang director 45 OLD MILLSTONE DRIVE, NIT 6, EAST WINDSOR NJ 08520

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Headlines

No Headlines